Further study of DCE parameters for PSM in PCa patients categorized by their PSA titers (e.g., >20 ng/mL, 10–20 ng/mL, and <10 ng/mL) may provide more information; however, more patients are required to obtain sufficient statistical power. This evidence concerns the gene KLK3 and posterior cortical atrophy.